openPR Logo
Press release

Cancer Clinical Decision Tools Market Trends, Top Companies, Share, Growth And Forecast 2033

06-05-2024 11:24 AM CET | Health & Medicine

Press release from: The Business research company

Cancer Clinical Decision Tools Market

Cancer Clinical Decision Tools Market

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Cancer Clinical Decision Tools Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $0.72 billion In 2028 At A CAGR Of 9.6% :

The cancer clinical decision tools market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to growing prevalence of cancer, increasing complexity of cancer treatment, rising demand for personalized medicine, growing adoption of value-based healthcare, increasing availability of cancer data, government support for cancer research and development.

The cancer clinical decision tools market size is expected to see rapidly grown in the next few years. It will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to global aging population, patient engagement and shared decision-making, patient-centric care, clinical research and evidence-based medicine. Major trends in the forecast period include advancements in medical imaging, ai-driven clinical decision support, telemedicine and remote consultations, predictive analytics, interoperability and data standards, ethical and regulatory considerations.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp

Cancer Clinical Decision Tools Market Major Segments
The cancer clinical decision tools market covered in this report is segmented -

1) By Type: Risk Assessment Tool(RAT), Qcancer
2) By End-User: Hospital, Clinics

Key Driver - Rise In Cancer Cases Drives Demand For Cancer Clinical Decision Tools

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the cancer clinical decision tools market growth.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=3463&type=smp

Prominent Trend - Innovative Products Transforming Cancer Clinical Decision Tools Market

Major companies operating in the cancer clinical decision tools market are exploring innovative products such as the BenchMark Ultra Plus tissue staining system to gain a competitive advantage. The BenchMark Ultra Plus system optimizes tissue staining for faster and more accurate pathology results. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, launched the BenchMark Ultra Plus tissue staining system, which boasts improved workflow efficiency, testing processes, and sustainability features. This innovative system empowers pathologists to deliver high-quality, time-sensitive results to medical professionals and patients. The BenchMark Ultra Plus system represents the next step in the BenchMark series' evolution, automating previously manual slide-by-slide processes and revolutionizing cancer diagnostics.

Cancer Clinical Decision Tools Market Players
Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, IBM Watson Health, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Koninklijke Philips N.V., RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the cancer clinical decision tools market in 2023. The regions covered in the cancer clinical decision tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cancer Clinical Decision Tools Market Report Structure
3. Cancer Clinical Decision Tools Market Trends And Strategies
4. Cancer Clinical Decision Tools Market - Macro Economic Scenario
5. Cancer Clinical Decision Tools Market Size And Growth
…..
27. Cancer Clinical Decision Tools Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Clinical Decision Tools Market Trends, Top Companies, Share, Growth And Forecast 2033 here

News-ID: 3526937 • Views:

More Releases from The Business research company

An Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Processed Animal Protein Market
An Overview of Segmentation, Market Dynamics, and Competitive Landscape in the P …
The processed animal protein market is positioned for notable expansion in the years ahead, driven by evolving consumer preferences and technological advancements. As sustainability and quality become focal points, this industry is adapting to meet diverse demands across various applications, from aquaculture feeds to pet nutrition. Let's explore the market's growth outlook, key players, emerging trends, and segmentation in more detail. Forecasted Growth Trajectory of the Processed Animal Protein Market Size
Segment Analysis and Major Growth Areas in the Coffee Extracts Market Preparation
Segment Analysis and Major Growth Areas in the Coffee Extracts Market Preparatio …
The coffee extracts market is on the rise, driven by evolving consumer preferences and innovations in product development. As the demand for high-quality and functional coffee products grows, this sector is set to experience notable expansion in the coming years. Below, we explore the market size projections, key players, emerging trends, and the major segments shaping the preparation of coffee extracts industry. Projected Market Size and Growth Outlook for Coffee Extracts
Emerging Growth Factors Fueling the Expansion of the Powdered Sugar Market
Emerging Growth Factors Fueling the Expansion of the Powdered Sugar Market
The powdered sugar market is on a promising growth path, driven by evolving consumer preferences and expanding applications across various food sectors. As demand for high-quality and specialty ingredients rises, this market is set to witness considerable expansion by 2030. Let's explore the market's size, key players, and the primary segments shaping its future. Projected Market Growth and Size of the Powdered Sugar Market The powdered sugar market is anticipated
Emerging Sub-Segments Transforming the Pork Meat Market Landscape
Emerging Sub-Segments Transforming the Pork Meat Market Landscape
The pork meat market is gearing up for notable expansion over the coming years, driven by evolving consumer preferences and advancements across the supply chain. Increasing focus on quality, sustainability, and convenience is set to fuel this sector's growth, making it an exciting area to watch through 2030. Projected Growth Trajectory of the Pork Meat Market The pork meat market is anticipated to grow significantly, reaching a valuation of $581.72

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For